Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Net Margin: 2009-2025

Historic Net Margin for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -11.39%.

  • Rockwell Medical's Net Margin fell 1727.00% to -11.39% in Q3 2025 from the same period last year, while for Sep 2025 it was -7.57%, marking a year-over-year decrease of 617.00%. This contributed to the annual value of -0.55% for FY2024, which is 993.00% up from last year.
  • Per Rockwell Medical's latest filing, its Net Margin stood at -11.39% for Q3 2025, which was down 17.64% from -9.68% recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Net Margin ranged from a high of 5.88% in Q3 2024 and a low of -58.32% during Q4 2021.
  • Moreover, its 3-year median value for Net Margin was -8.31% (2025), whereas its average is -6.95%.
  • As far as peak fluctuations go, Rockwell Medical's Net Margin slumped by 1,738bps in 2021, and later skyrocketed by 4,609bps in 2022.
  • Quarterly analysis of 5 years shows Rockwell Medical's Net Margin stood at -58.32% in 2021, then spiked by 4,609bps to -12.23% in 2022, then spiked by 493bps to -7.30% in 2023, then surged by 414bps to -3.16% in 2024, then tumbled by 1,727bps to -11.39% in 2025.
  • Its last three reported values are -11.39% in Q3 2025, -9.68% for Q2 2025, and -8.31% during Q1 2025.